Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

100 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Completed

A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence

NCT03194542

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +3 more
Locations
  • Local Institution - 102 Phoenix, Arizona, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • Local Institution - 103 Stanford, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 47 locations
View Trial Details
Completed

Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia

NCT02124746

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • Scottsdale, Arizona, United States
  • Orange, California, United States
  • Stanford, California, United States
  • Whittier, California, United States
View all 22 locations
View Trial Details
Completed

Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated With Ruxolitinib

NCT04884191

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
View all 62 locations
View Trial Details
Completed

A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms

NCT01387763

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Dept of Hematology, Aalborg hospital Aalborg, Denmark
  • Dept. of Hematology, Aarhus University Hospital Aarhus, Denmark
  • Dept of Hematology, Rigshospitalet Copenhagen, Denmark
  • Dept of Hematology, Esbjerg Hospital Esbjerg, Denmark
View Trial Details
Completed

Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

NCT01423851

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Mayo Clinic Scottsdale Recruiting Scottsdale, Arizona, United States
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • Mayo Clinic, Jacksonville Jacksonville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Completed

A Phase 2 Study of RO7490677 In Participants With Myelofibrosis

NCT01981850

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Fibrosis, +11 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory Hospital Atlanta, Georgia, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
View all 23 locations
View Trial Details

Related conditions